TY - JOUR T1 - The seasonality of cholera in sub-Saharan Africa JF - medRxiv DO - 10.1101/2021.11.23.21265642 SP - 2021.11.23.21265642 AU - Javier Perez-Saez AU - Justin Lessler AU - Elizabeth C. Lee AU - Francisco J. Luquero AU - Espoir Bwenge Malembaka AU - Flavio Finger AU - José Paulo Langa AU - Sebastian Yennan AU - Ben Zaitchik AU - Andrew S Azman Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/24/2021.11.23.21265642.abstract N2 - Background Cholera remains a major threat in Sub-Saharan Africa (SSA) where some of the highest case fatality risks are reported. Knowing in what months and where cholera tends to occur across the continent can aid in improving efforts to eliminate cholera as a public health concern; though largely due to lack of unified large-scale datasets, no continent-wide estimates exist. In this study we aim to estimate cholera seasonality across SSA.Methods We leverage the Global Task Force on Cholera Control (GTFCC) global cholera database with statistical models to synthesize data across spatial and temporal scale in order to infer the seasonality of excess suspected cholera occurrence in SSA. We developed a Bayesian statistical model to infer the monthly risk of excess cholera at the first and/or second administrative levels. Seasonality patterns were then grouped into spatial clusters. Finally, we studied the association between seasonality estimates and hydro-climatic variables.Findings The majority of studied countries (24/34) have seasonal patterns in excess cholera, corresponding to approximately 85% of the SSA population. Most countries (19/24) also had sub-national differences in seasonality patterns, with strong differences in seasonality strength between regions. Seasonality patterns clustered into two macro-regions (West Africa and the Sahel vs. Eastern and Southern Africa), which were composed of sub-regional clusters with varying degrees of seasonality. Exploratory association analysis found most consistent and positive correlations between cholera seasonality and precipitation, and to a lesser extent with temperature and flooding.Interpretation Widespread cholera seasonality in SSA offers opportunities for intervention planning. Further studies are needed to study the association between cholera and climate.Funding The NASA Applied Sciences Program and the Bill and Melinda Gates Foundation.Evidence before this study Previous studies were searched using PubMed on Nov 15, 2021, without language or date restrictions using the search terms [“cholera*” AND “season*” AND (“Africa*” OR “Angola” OR “Burundi” OR “Benin” OR “Burkina Faso” OR “Botswana” OR “Central African Republic” OR “Côte d’Ivoire” OR “Cameroon” OR “Democratic Republic of the Congo” OR “Republic of Congo” OR “Djibouti” OR “Eritrea” OR “Ethiopia” OR “Gabon” OR “Ghana” OR “Guinea” OR “Gambia” OR “Guinea-Bissau” OR “Equatorial Guinea” OR “Kenya” OR “Liberia” OR “Madagascar” OR “Mali” OR “Mozambique” OR “Mauritania” OR “Malawi” OR “Namibia” OR “Niger” OR “Nigeria” OR “Rwanda” OR “Sudan” OR “Senegal” OR “Sierra Leone” OR “Somalia” OR “South Sudan” OR “São Tomé and Príncipe” OR “Swaziland” OR “Chad” OR “Togo” OR “Tanzania” OR “Uganda” OR “South Africa” OR “Zambia” OR “Zimbabwe”)]. Two additional known articles not identified by our PubMed search were added, one on the seasonality of cholera in Kenya and one on the epidemiology of cholera in West Africa. Studies were included if they focused on the epidemiology of Vibrio cholerae O1 or O139, covering one or multiple countries in sub-Saharan Africa (SSA) for at least two years with reported cases. We identified a total of 140 studies, of which 36 met our inclusion criteria. Of these 4 were reviews, 3 were regional or global studies, and 29 focused on specific countries. Local-level seasonality studies were identified in Burundi (1), Côte d’Ivoire (1), Cameroon (2), Democratic Republic of the Congo (3), Ghana (1), Guinea-Bissau (1), Kenya (1), Mozambique (3), Nigeria (1), Senegal (1), Somalia (1), South Sudan (1), Togo (1), Tanzania (4), Uganda (2), South Africa (1), and Zambia (4). These local studies mainly consisted of epidemiological descriptions of cholera incidence at either the national or first administrative unit scale, covering between 2 and 31 years of data. Most of these studies found seasonality in cholera with different patterns between countries. Two regional studies in West Africa found seasonal patterns in cholera incidence in the second part of the calendar year, with evidence for synchrony with rainfall patterns. Finally one global study between 1975 and 2005 found evidence for a latitudinal gradient of seasonality strength with weaker seasonality around the equator.Added value of this study Although most local-level and regional studies have found evidence for cholera seasonal patterns in SSA, gaps remain for certain countries and there currently lacks a systematic and continental-scale investigation. By leveraging a large database of cholera incidence we evaluate and characterize cholera seasonality at sub-national scale in 34 countries of SSA for which sufficient data was available. We show that cholera is seasonal in the majority of countries (24/34), with sub-national heterogeneity in most of them (19/24). Results enable the description of cholera seasonality at the continental level and the exploration of associations with hydro-climatic variables.Implications of all the available evidence This work establishes the extent and strength of cholera seasonality in SSA, providing a basis on which to ground strategic decision on large-scale intervention allocation as well as future work on the climatic and non-climatic drivers of cholera seasonality in SSA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJL, ASA, and ECL were supported by the Bill and Melinda Gates Foundation (INV- 002667). JL, BZ, ASA, ECL were supported by the NASA applied sciences program grant 80NSSC18K0327. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data used in these analyses were not identifiable and this work was deemed to be nonhuman subjects research by the Johns Hopkins IRB.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode, results and a minimal dataset are available at https://github.com/HopkinsIDD/cholera_seasonality_ssa/ ER -